Genocea Biosciences (OTC: GNCA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Genocea Biosciences (OTCPK: GNCA) through any online brokerage.
There are no as such competitors for Genocea Biosciences.
The latest price target for Genocea Biosciences (OTCPK: GNCA) was reported by HC Wainwright & Co. on Friday, April 29, 2022. The analyst firm set a price target for 0.00 expecting GNCA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Genocea Biosciences (OTCPK: GNCA) is $0.015 last updated July 1, 2022, 7:16 PM UTC.
There are no upcoming dividends for Genocea Biosciences.
Genocea Biosciences’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Genocea Biosciences.
Genocea Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.